Cargando…

Strategies and interventions to strengthen pharmacovigilance systems in low-income and middle-income countries: a scoping review

OBJECTIVES: The slow progress of pharmacovigilance (PV) in low-income and middle-income countries (LMIC) raises questions about core challenges on the growth of PV, and the appropriateness of strategies used so far to develop PV. Therefore, this scoping review aims to describe strategies and interve...

Descripción completa

Detalles Bibliográficos
Autores principales: Menang, Olga, Kuemmerle, Andrea, Maigetter, Karen, Burri, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503375/
https://www.ncbi.nlm.nih.gov/pubmed/37709326
http://dx.doi.org/10.1136/bmjopen-2022-071079
_version_ 1785106513545658368
author Menang, Olga
Kuemmerle, Andrea
Maigetter, Karen
Burri, Christian
author_facet Menang, Olga
Kuemmerle, Andrea
Maigetter, Karen
Burri, Christian
author_sort Menang, Olga
collection PubMed
description OBJECTIVES: The slow progress of pharmacovigilance (PV) in low-income and middle-income countries (LMIC) raises questions about core challenges on the growth of PV, and the appropriateness of strategies used so far to develop PV. Therefore, this scoping review aims to describe strategies and interventions to strengthen PV in LMIC and to propose recommendations for future investments in PV capacity building. INCLUSION CRITERIA: Publications included were primary studies, articles, policy and guideline papers, describing interventions to strengthen PV in LMIC. METHODS: The review was conducted following the Joanna Briggs Institute (JBI) guidelines on conducting scoping reviews. Literature searches were performed in MEDLINE, EMBASE, Web of Science, PDQ-evidence, CINAHL and other relevant websites from January 1990 to January 2021. Two reviewers independently screened titles, abstracts and full texts. One reviewer performed data extraction and descriptive analysis, which were reviewed by two other reviewers. RESULTS: 10 922 unique titles were screened and 152 were eligible for full text review. Of these, 57 and an additional 13 reports from grey literature fulfilled eligibility criteria for inclusion in the review. These were grouped into two categories: (1) Interventions aimed at increasing PV knowledge and adverse drug reactions (ADR) reporting (45 papers), primarily education of healthcare professionals (HCP), alone or in combination with other interventions such as mobile and electronic reporting and (2) Interventions aimed at strengthening various components of the national PV system (25 papers), describing strategies or mixed interventions implemented at the national level, targeting different components of the national PV system. CONCLUSIONS: Results of this review suggest that educating HCP on ADR reporting is the most common approach to build PV capacity in LMIC. Though important, education alone is insufficient and should ideally be organised within the holistic framework of strengthening national PV systems, with a focus on also building capacity for advanced activities such as signal detection.
format Online
Article
Text
id pubmed-10503375
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-105033752023-09-16 Strategies and interventions to strengthen pharmacovigilance systems in low-income and middle-income countries: a scoping review Menang, Olga Kuemmerle, Andrea Maigetter, Karen Burri, Christian BMJ Open Public Health OBJECTIVES: The slow progress of pharmacovigilance (PV) in low-income and middle-income countries (LMIC) raises questions about core challenges on the growth of PV, and the appropriateness of strategies used so far to develop PV. Therefore, this scoping review aims to describe strategies and interventions to strengthen PV in LMIC and to propose recommendations for future investments in PV capacity building. INCLUSION CRITERIA: Publications included were primary studies, articles, policy and guideline papers, describing interventions to strengthen PV in LMIC. METHODS: The review was conducted following the Joanna Briggs Institute (JBI) guidelines on conducting scoping reviews. Literature searches were performed in MEDLINE, EMBASE, Web of Science, PDQ-evidence, CINAHL and other relevant websites from January 1990 to January 2021. Two reviewers independently screened titles, abstracts and full texts. One reviewer performed data extraction and descriptive analysis, which were reviewed by two other reviewers. RESULTS: 10 922 unique titles were screened and 152 were eligible for full text review. Of these, 57 and an additional 13 reports from grey literature fulfilled eligibility criteria for inclusion in the review. These were grouped into two categories: (1) Interventions aimed at increasing PV knowledge and adverse drug reactions (ADR) reporting (45 papers), primarily education of healthcare professionals (HCP), alone or in combination with other interventions such as mobile and electronic reporting and (2) Interventions aimed at strengthening various components of the national PV system (25 papers), describing strategies or mixed interventions implemented at the national level, targeting different components of the national PV system. CONCLUSIONS: Results of this review suggest that educating HCP on ADR reporting is the most common approach to build PV capacity in LMIC. Though important, education alone is insufficient and should ideally be organised within the holistic framework of strengthening national PV systems, with a focus on also building capacity for advanced activities such as signal detection. BMJ Publishing Group 2023-09-14 /pmc/articles/PMC10503375/ /pubmed/37709326 http://dx.doi.org/10.1136/bmjopen-2022-071079 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Public Health
Menang, Olga
Kuemmerle, Andrea
Maigetter, Karen
Burri, Christian
Strategies and interventions to strengthen pharmacovigilance systems in low-income and middle-income countries: a scoping review
title Strategies and interventions to strengthen pharmacovigilance systems in low-income and middle-income countries: a scoping review
title_full Strategies and interventions to strengthen pharmacovigilance systems in low-income and middle-income countries: a scoping review
title_fullStr Strategies and interventions to strengthen pharmacovigilance systems in low-income and middle-income countries: a scoping review
title_full_unstemmed Strategies and interventions to strengthen pharmacovigilance systems in low-income and middle-income countries: a scoping review
title_short Strategies and interventions to strengthen pharmacovigilance systems in low-income and middle-income countries: a scoping review
title_sort strategies and interventions to strengthen pharmacovigilance systems in low-income and middle-income countries: a scoping review
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503375/
https://www.ncbi.nlm.nih.gov/pubmed/37709326
http://dx.doi.org/10.1136/bmjopen-2022-071079
work_keys_str_mv AT menangolga strategiesandinterventionstostrengthenpharmacovigilancesystemsinlowincomeandmiddleincomecountriesascopingreview
AT kuemmerleandrea strategiesandinterventionstostrengthenpharmacovigilancesystemsinlowincomeandmiddleincomecountriesascopingreview
AT maigetterkaren strategiesandinterventionstostrengthenpharmacovigilancesystemsinlowincomeandmiddleincomecountriesascopingreview
AT burrichristian strategiesandinterventionstostrengthenpharmacovigilancesystemsinlowincomeandmiddleincomecountriesascopingreview